HIV-positive (n = 41) | HIV-negative (n = 2210) | P | |
---|---|---|---|
Demographicsa | |||
Age, years, mean (SD) | 49.6 (12) | 60.4 (15.5) | <0.0001 |
Gender, male (%) | 24 (75) | 1154 (6) | 0.14 |
Race, white (%) | 18 (56.2) | 1652 (89) | 0.005 |
Admissions | |||
Readmission (%) | 9 (22.0) | 353 (16.0) | 0.39 |
New HIV diagnosis (%) | 6 (14.6) | -- | -- |
Severity of disease in first 24 hours | |||
SOFA score, median (IQR)b | 7 (3-10.5) | 7 (4–9) | 0.38 |
Organ failure (%) | 35 (85.4) | 1802 (81.5) | 1 |
Shock (%) | 9 (22) | 606 (27.4) | 0.50 |
HIV disease severity and treatment | |||
CD4 count, cells/mm3, median (IQR)c | 70 (23-346) | -- | -- |
Viral load, cp/ml, median (IQR)d | 105 (48-54916) | -- | -- |
On cART (%) | 29 (70.7) | -- | -- |
Viral suppression (%) | 18 (47.4) | -- | -- |
Outcome | |||
Length of ICU stay, median days (IQR) | 4 (1–11) | 4 (2–8) | 0.47 |
Organ failure during admission (%) | 37 (90.2) | 1915 (86.7) | 0.73 |
Shock during admission (%) | 15 (36.6) | 750 (33.9) | 0.74 |
30-day mortality (%)a | 6 (18.8) | 481 (25.9) | 0.42 |
60-day mortality (%)a | 11 (34.4) | 568 (30.6) | 0.72 |
90-day mortality (%)a | 13 (40.6) | 629 (33.9) | 0.57 |
1-year mortality (%)a | 16 (50) | 794 (42.8) | 0.35 |